Health Condition 1: G969- Disorder of central nervous system, unspecified Health Condition 2: G998- Other specified disorders of nervous system in diseases classified elsewhere
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Intervention3: Nil: Nil
Intervention4: Nil: Nil
Intervention5: Nil: Nil
Intervention6: Automated oropharyngeal and subglottic suction device (AOPS): The
Sponsors
NIMHANS
INNACCEL Technologies Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Patients admitted to Neuro critical care ICU requiring mechanical ventilation
Exclusion criteria
Exclusion criteria: Patients with tracheostomy, latex allergy, oropharyngeal bleeding or bleeding disorders, faciomaxillary or cervical spine injuries Patients admitted with primary lung pathology. Severe immune dysfunction Non provision of consent for participation in the study by self or relatives. Vulnerable populations such as patients with mental illness, physical disabilities, elderly individuals, pregnant or lactating women, patients with chronic neurological disorders and terminally ill patients will be excluded from study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the average per day total direct costs of ICU stay between automated and manual suction strategies.Timepoint: Patients will be included at baseline (Day 0), defined as ICU admission following surgery or intervention. Outcome and clinical variables will be assessed once daily (Day 1 onwards) throughout the ICU stay. Final assessment will occur at ICU discharge, death, or study withdrawal, whichever occurs first. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the economic burden of equipment,consumable, drugs,investigations,human resource utilization between the two groups during ICU stay, under the following headers: 1.Medications 2.Diagnostic Investigations (Cultures, Imaging) 3.Intervention charges (Surgical, Radiology) 4.Consumables (RT, ET tube, foleys, arterial line, IV cannula, central line, Suction bottle, Tubing s, AOPS consumables) 5.ICU Stay,ICU bed, Ventilator, AOPS device, Monitoring (Multiparameter monitor, EEG, TCD, arterial, ICP, Ultrasound) 6.ICU Stay & Admission charges 7.Human resources (Doctor, Nursing, Physiotherapy, Dietician etc)Timepoint: Patients will be included at baseline (Day 0), defined as ICU admission following surgery or intervention. Outcome & clinical variables will be assessed once daily (Day 1 onwards) throughout the ICU stay. Final assessment will occur at ICU discharge, death, or study withdrawal, whichever occurs first.;To compare the duration of mechanical ventilation between AOPS & standard care groupsTimepoint: Patients will be included at baseline (Day 0), defined as ICU admission following surgery or intervention. Outcome & clinical variables will be assessed once daily (Day 1 onwards) throughout the ICU stay. Final assessment will occur at ICU discharge, death, or study withdrawal, whichever occurs first.;To quantify antibiotic consumption in patients managed between automated & manual suction strategies.Timepoint: Patients will be included at baseline (Day 0), defined as ICU admission following surgery or intervention. Outcome & clinical variables will be assessed once daily (Day 1 onwards) throughout the ICU stay. Final assessment will occur at ICU discharge, death, or study withdrawal, whichever occurs first.;To evaluate the impact on the need for reserve antibiotics & escalation/de-escalation patterns between two groups.Timepoint: Patients will be included at baseline (Day 0), defined as ICU admission following surgery or intervention. Outcome & clinical | — |
Countries
India
Contacts
Public ContactManisha J
NIMHANS
Outcome results
None listed